Regulated Expression of the α Isoform of the Human Thromboxane A2 Receptor during Megakaryocyte Differentiation: A Coordinated Role for WT1, Egr1, and Sp1

Journal of Molecular Biology

Volumn 394, Issue 1, 2009, Pages 29-45

  Gannon, AnneMarie M ^a   Turner, Elizebeth C ^a   Reid, Helen M ^a   Kinsella, B Therese ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Egr1; megakaryocytic differentiation; Sp1; thromboxane receptor gene; WT1

Indexed keywords

BINDING PROTEIN; CIS ACTING ELEMENT; EARLY GROWTH RESPONSE FACTOR 1; ISOPROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBOXANE; THROMBOXANE A2 RECEPTOR; TRANSCRIPTION FACTOR SP1; WT1 PROTEIN;

ARTICLE; BLOOD VESSEL TONE; CELL DIFFERENTIATION; CELL STRAIN K 562; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; GENE DELETION; GENE EXPRESSION; HEMOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MEGAKARYOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL DIFFERENTIATION; DNA MUTATIONAL ANALYSIS; EARLY GROWTH RESPONSE PROTEIN 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GC RICH SEQUENCE; GENE EXPRESSION REGULATION; HUMANS; K562 CELLS; LUCIFERASES; MAP KINASE SIGNALING SYSTEM; MEGAKARYOCYTES; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PROTAMINES; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; REPRESSOR PROTEINS; RNA, MESSENGER; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; WT1 PROTEINS;

EID: 70350211070     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.09.007     Document Type: Article

References (51)

1. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79 (1999) 1193-1226
2. Moncada S., and Vane J.R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N. Engl. J. Med. 300 (1979) 1142-1147
3. Morinelli T.A., Naka M., Masuda A., Oatis Jr. J.E., Okwu A.K., Mais D.E., et al. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Adv. Prostaglandin, Thromboxane, Leukotriene Res. 21A (1991) 331-337
4. Fitzgerald D.J., Rocki W., Murray R., Mayo G., and FitzGerald G.A. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335 (1990) 751-754
5. Gryglewski R.J., Dembinska-Kiec A., Zmuda A., and Gryglewska T. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis 31 (1978) 385-394
6. Hirsh P.D., Hillis L.D., Campbell W.B., Firth B.G., and Willerson J.T. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N. Engl. J. Med. 304 (1981) 685-691
7. Salvati P., Dho L., Ukmar G., Vaga L., Rimoldi O., and Patrono C. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis. J. Pharmacol. Exp. Ther. 269 (1994) 238-245
8. Nusing R.M., Hirata M., Kakizuka A., Eki T., Ozawa K., and Narumiya S. Characterization and chromosomal mapping of the human thromboxane A2 receptor gene. J. Biol. Chem. 268 (1993) 25253-25259
9. Raychowdhury M.K., Yukawa M., Collins L.J., McGrail S.H., Kent K.C., and Ware J.A. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J. Biol. Chem. 269 (1994) 19256-19261
10. Hirata T., Ushikubi F., Kakizuka A., Okuma M., and Narumiya S. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J. Clin. Invest. 97 (1996) 949-956
11. Reid H.M., and Kinsella B.T. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for nitric oxide-mediated desensitization. Independent modulation of Tp alpha signaling by nitric oxide and prostacyclin. J. Biol. Chem. 278 (2003) 51190-51202
12. Walsh M.T., Foley J.F., and Kinsella B.T. The alpha, but not the beta, isoform of the human thromboxane A2 receptor is a target for prostacyclin-mediated desensitization. J. Biol. Chem. 275 (2000) 20412-20423
13. Kelley-Hickie L.P., and Kinsella B.T. Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor. Biochim. Biophys. Acta 1761 (2006) 1114-1131
14. Parent J.L., Labrecque P., Orsini M.J., and Benovic J.L. Internalization of the TXA2 receptor alpha and beta isoforms. Role of the differentially spliced COOH terminus in agonist-promoted receptor internalization. J. Biol. Chem. 274 (1999) 8941-8948
15. Miggin S.M., and Kinsella B.T. Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms. Biochim. Biophys. Acta 1425 (1998) 543-559
16. Habib A., FitzGerald G.A., and Maclouf J. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J. Biol. Chem. 274 (1999) 2645-2651
17. Coyle A.T., Miggin S.M., and Kinsella B.T. Characterization of the 5′ untranslated region of alpha and beta isoforms of the human thromboxane A2 receptor (TP). Differential promoter utilization by the TP isoforms. Eur. J. Biochem. 269 (2002) 4058-4073
18. Coyle A.T., and Kinsella B.T. Characterization of promoter 3 of the human thromboxane A receptor gene. A functional AP-1 and octamer motif are required for basal promoter activity. FEBS J. 272 (2005) 1036-1053
19. Coyle A.T., O'Keeffe M.B., and Kinsella B.T. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. FEBS J. 272 (2005) 4754-4773
20. Coyle A.T., and Kinsella B.T. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. Biochem. Pharmacol. 71 (2006) 1308-1323
21. Gannon A.M., and Kinsella B.T. Regulation of the human thromboxane A2 receptor gene by Sp1, Egr1, NF-E2, GATA-1 and Ets-1 in megakaryocytes. J. Lipid Res. 49 (2008) 2590-2604
22. Gannon A.M., and Kinsella B.T. The Wilms' tumor suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes. J. Cell. Mol. Med. (2008) 10.111/j.1582-4934.2008
23. Long M.W., Heffner C.H., Williams J.L., Peters C., and Prochownik E.V. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J. Clin. Invest. 85 (1990) 1072-1084
24. Tabilio A., Rosa J.P., Testa U., Kieffer N., Nurden A.T., Del Canizo M.C., et al. Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). EMBO J. 3 (1984) 453-459
25. D'Angelo D.D., Oliver B.G., Davis M.G., McCluskey T.S., and Dorn G.W. Novel role for Sp1 in phorbol ester enhancement of human platelet thromboxane receptor gene expression. J. Biol. Chem. 271 (1996) 19696-19704
26. Nakagama H., Heinrich G., Pelletier J., and Housman D.E. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol. Cell. Biol. 15 (1995) 1489-1498
27. Rajput B., Shaper N.L., and Shaper J.H. Transcriptional regulation of murine beta1,4-galactosyltransferase in somatic cells. Analysis of a gene that serves both a housekeeping and a mammary gland-specific function. J. Biol. Chem. 271 (1996) 5131-5142
28. Jackson S.P., MacDonald J.J., Lees-Miller S., and Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63 (1990) 155-165
29. Phelan S.A., Lindberg C., and Call K.M. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ. 5 (1994) 677-686
30. Hirata M., Hayashi Y., Ushikubi F., Yokota Y., Kageyama R., Nakanishi S., and Narumiya S. Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349 (1991) 617-620
31. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4 (1994) 96-101
32. Hipskind R.A., Baccarini M., and Nordheim A. Transient activation of RAF-1, MEK, and ERK2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. Mol. Cell. Biol. 14 (1994) 6219-6231
33. Zhang F., Lin M., Abidi P., Thiel G., and Liu J. Specific interaction of Egr1 and c/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene. J. Biol. Chem. 278 (2003) 44246-44254
34. Huang R.P., and Adamson E.D. The phosphorylated forms of the transcription factor, Egr-1, bind to DNA more efficiently than non-phosphorylated. Biochem. Biophys. Res. Commun. 200 (1994) 1271-1276
35. Silverman E.S., and Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154 (1999) 665-670
36. Vajjhala P.R., Macmillan E., Gonda T., and Little M. The Wilms' tumour suppressor protein, WT1, undergoes CRM1-independent nucleocytoplasmic shuttling. FEBS Lett. 554 (2003) 143-148
37. Ye Y., Raychaudhuri B., Gurney A., Campbell C.E., and Williams B.R. Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J. 15 (1996) 5606-5615
38. Marcet-Palacios M., Ulanova M., Duta F., Puttagunta L., Munoz S., Gibbings D., et al. The transcription factor Wilms tumor 1 regulates matrix metalloproteinase-9 through a nitric oxide-mediated pathway. J. Immunol. 179 (2007) 256-265
39. Goodwin A.J., McInerney J.M., Glander M.A., Pomerantz O., and Lowrey C.H. In vivo formation of a human beta-globin locus control region core element requires binding sites for multiple factors including GATA-1, NF-E2, erythroid Kruppel-like factor, and Sp1. J. Biol. Chem. 276 (2001) 26883-26892
40. Kumar A.P., and Butler A.P. Serum responsive gene expression mediated by Sp1. Biochem. Biophys. Res. Commun. 252 (1998) 517-523
41. Liao M., Zhang Y., and Dufau M.L. PKC{alpha}-induced derepression of the human LH receptor gene transcription through ERK-mediated release of HDAC1/Sin3A corepressor complex from Sp1 sites. Mol. Endocrinol. 22 (2008) 1449-1463
42. Cheng T., Wang Y., and Dai W. Transcription factor egr-1 is involved in phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells. J. Biol. Chem. 269 (1994) 30848-30853
43. Jalagadugula G., Dhanasekaran D.N., Kim S., Kunapuli S.P., and Rao A.K. Early growth response transcription factor EGR-1 regulates Galphaq gene in megakaryocytic cells. J. Thromb. Haemost. 4 (2006) 2678-2686
44. Jalagadugula G., Dhanasekaran D.N., and Rao A.K. Phorbol 12-myristate 13-acetate (PMA) responsive sequence in Galphaq promoter during megakaryocytic differentiation. Regulation by EGR-1 and MAP kinase pathway. Thromb. Haemostasis 100 (2008) 821-828
45. Offermanns S., Toombs C.F., Hu Y.H., and Simon M.I. Defective platelet activation in G alpha(q)-deficient mice. Nature 389 (1997) 183-186
46. McCaffrey T.A., Fu C., Du B., Eksinar S., Kent K.C., Bush Jr. H., et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J. Clin. Invest. 105 (2000) 653-662
47. Thiel G., Kaufmann K., Magin A., Lietz M., Bach K., and Cramer M. The human transcriptional repressor protein NAB1: expression and biological activity. Biochim. Biophys. Acta 1493 (2000) 289-301
48. Sobue S., Hagiwara K., Banno Y., Tamiya-Koizumi K., Suzuki M., Takagi A., et al. Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12. J. Neurochem. 95 (2005) 940-949
49. Wagner N., Michiels J.F., Schedl A., and Wagner K.D. The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo. Oncogene 27 (2008) 3662-3672
50. Zhang F., Ahlborn T.E., Li C., Kraemer F.B., and Liu J. Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol-independent regulatory element of human LDL receptor promoter. J. Lipid Res. 43 (2002) 1477-1485
51. Niksic M., Slight J., Sanford J.R., Caceres J.F., and Hastie N.D. The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum. Mol. Genet. 13 (2004) 463-471